Crossref
journal-article
Elsevier BV
Journal of Controlled Release (78)
References
47
Referenced
39
{'key': '10.1016/j.jconrel.2005.03.007_bib1', 'first-page': '891', 'article-title': 'Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes', 'volume': '52', 'author': 'Gabizon', 'year': '1992', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes by Gabizon (1992)10.1002/j.1552-4604.1996.tb04152.x
/ J. Clin. Pharmacol. / Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma by Northfelt (1996)10.1200/JCO.1996.14.8.2353
/ J. Clin. Oncol. / Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma by Gill (1996){'key': '10.1016/j.jconrel.2005.03.007_bib4', 'series-title': 'Anthracyclines: Current Status and New Developments', 'first-page': '403', 'article-title': 'Effects of modifications in position 4 of the chromophore or in position 4′ of the aminosugar, on the antitumor acitivity and toxicity of daunorubicin and doxorubicin', 'author': 'Casazza', 'year': '1980'}
/ Anthracyclines: Current Status and New Developments / Effects of modifications in position 4 of the chromophore or in position 4′ of the aminosugar, on the antitumor acitivity and toxicity of daunorubicin and doxorubicin by Casazza (1980){'key': '10.1016/j.jconrel.2005.03.007_bib5', 'first-page': '829', 'article-title': 'Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers', 'volume': '60', 'author': 'Arcamone', 'year': '1976', 'journal-title': 'Cancer Treat. Rep.'}
/ Cancer Treat. Rep. / Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers by Arcamone (1976){'key': '10.1016/j.jconrel.2005.03.007_bib6', 'first-page': '70', 'article-title': 'Selected pharmacologic characteristics of idarubicin and idarubicinol', 'volume': '6', 'author': 'Ames', 'year': '1992', 'journal-title': 'Leukemia'}
/ Leukemia / Selected pharmacologic characteristics of idarubicin and idarubicinol by Ames (1992){'key': '10.1016/j.jconrel.2005.03.007_bib7', 'first-page': '835', 'article-title': 'Experimental evaluation of anthracycline analogs', 'volume': '63', 'author': 'Casazza', 'year': '1979', 'journal-title': 'Cancer Treat. Rep.'}
/ Cancer Treat. Rep. / Experimental evaluation of anthracycline analogs by Casazza (1979)10.1016/S0006-2952(02)00920-6
/ Biochem. Pharmacol. / Formation and longevity of idarubicin-induced DNA topoisomerase II cleavable complexes in K562 human leukaemia cells by Willmore (2002)10.1007/BF02897289
/ Cancer Chemother. Pharmacol. / Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells by Limonta (1990)10.1016/0006-2952(95)02069-1
/ Biochem. Pharmacol. / Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance by Ross (1995)10.1007/BF00686485
/ Cancer Chemother. Pharmacol. / Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture by Kuffel (1992)10.1016/S0145-2126(99)00041-7
/ Leuk. Res. / Idarubicin overcomes P-glycoprotein-related multidrug resistance: comparison with doxorubicin and daunorubicin in human multiple myeloma cell lines by Roovers (1999)10.1016/0145-2126(94)00157-6
/ Leuk. Res. / Evaluation of resistance index of several anticancer agents on parental and resistant P-388 cell lines by Testi (1995)10.1182/blood.V79.12.3267.3267
/ Blood / Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells by Berman (1992)10.1182/blood.V79.2.313.313
/ Blood / Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia by Wiernik (1992)10.1182/blood.V77.8.1666.1666
/ Blood / Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia by Berman (1991)10.1159/000226863
/ Oncology / Comparative phase II study of idarubicin versus doxorubicin in advanced breast cancer by Martoni (1990){'key': '10.1016/j.jconrel.2005.03.007_bib18', 'first-page': '739', 'article-title': 'Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors', 'volume': '68', 'author': 'Broggini', 'year': '1984', 'journal-title': 'Cancer Treat. Rep.'}
/ Cancer Treat. Rep. / Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors by Broggini (1984){'key': '10.1016/j.jconrel.2005.03.007_bib19', 'first-page': '665', 'article-title': 'Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines', 'volume': '67', 'author': 'Penco', 'year': '1983', 'journal-title': 'Cancer Treat. Rep.'}
/ Cancer Treat. Rep. / Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines by Penco (1983)10.1111/j.1432-1033.1996.00879.x
/ Eur. J. Biochem. / The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids by Gallois (1996)10.1016/0006-2952(95)00221-K
/ Biochem. Pharmacol. / The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity by Mulder (1995)10.1016/S0005-2736(02)00345-0
/ Biochim. Biophys. Acta / Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes by Dos Santos (2002)10.1016/0005-2736(79)90085-3
/ Biochim. Biophys. Acta / Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes by Olson (1979)10.1016/0167-4889(87)90047-4
/ Biochim. Biophys. Acta / Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages by Derksen (1987)10.1016/0005-2736(86)90105-7
/ Biochim. Biophys. Acta / Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient by Mayer (1986)10.1016/S0006-3495(89)82684-0
/ Biophys. J. / Proton flux in large unilamellar vesicles in response to membrane potentials and pH gradients by Redelmeier (1989)10.1016/S1359-0294(96)80015-X
/ Curr. Opin. Colloid Interface Sci. / Cryo-transmission electron microscopy of thin vitrified samples by Almgren (1996)10.1016/0005-2736(90)90018-J
/ Biochim. Biophys. Acta / Liposomes with entrapped doxorubicin exhibit extended blood residence times by Bally (1990)10.1016/0022-1759(83)90303-4
/ J. Immunol. Methods / Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays by Mosmann (1983){'key': '10.1016/j.jconrel.2005.03.007_bib30', 'first-page': '589', 'article-title': 'Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay', 'volume': '48', 'author': 'Alley', 'year': '1988', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay by Alley (1988)10.1016/S0006-3495(93)81385-7
/ Biophys. J. / Osmotic properties of large unilamellar vesicles prepared by extrusion by Mui (1993){'key': '10.1016/j.jconrel.2005.03.007_bib32', 'first-page': '205', 'article-title': 'P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs', 'volume': '1', 'author': 'Shabbits', 'year': '2002', 'journal-title': 'Mol. Cancer Ther.'}
/ Mol. Cancer Ther. / P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs by Shabbits (2002){'key': '10.1016/j.jconrel.2005.03.007_bib33', 'first-page': '5922', 'article-title': 'Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice', 'volume': '49', 'author': 'Mayer', 'year': '1989', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice by Mayer (1989)10.1007/BF00686017
/ Cancer Chemother. Pharmacol. / Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia by Mayer (1993)10.1038/bjc.1995.430
/ Br. J. Cancer / Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models by Webb (1995){'key': '10.1016/j.jconrel.2005.03.007_bib36', 'first-page': '337', 'article-title': 'Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors', 'volume': '292', 'author': 'Lim', 'year': '2000', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors by Lim (2000)10.1248/cpb.51.815
/ Chem. Pharm. Bull. (Tokyo) / Effects of poly(ethylene glycol) (PEG) chain length of PEG-lipid on the permeability of liposomal bilayer membranes by Hashizaki (2003)10.1016/S0005-2736(99)00192-3
/ Biochim. Biophys. Acta / Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles by Nicholas (2000)10.1016/S0006-3495(97)78066-4
/ Biophys. J. / Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes by Edwards (1997)10.1023/A:1020186505848
/ Biosci. Rep. / Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol) by Allen (2002)10.1021/bc990135y
/ Bioconjug. Chem. / Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles by Sou (2000)10.1016/0014-5793(96)00452-8
/ FEBS Lett. / Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time by Uster (1996){'key': '10.1016/j.jconrel.2005.03.007_bib43', 'first-page': '365', 'article-title': 'Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells', 'volume': '16', 'author': 'Bogush', 'year': '1996', 'journal-title': 'Anticancer Res.'}
/ Anticancer Res. / Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells by Bogush (1996)10.1097/00001813-199707000-00009
/ Anticancer Drugs / Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicin by Bennis (1997){'key': '10.1016/j.jconrel.2005.03.007_bib45', 'first-page': '3595', 'article-title': 'Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and-resistant P388 leukemia', 'volume': '48', 'author': 'Deffie', 'year': '1988', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and-resistant P388 leukemia by Deffie (1988){'key': '10.1016/j.jconrel.2005.03.007_bib46', 'first-page': '4243', 'article-title': 'Selective sensitization of adriamycin-resistant P388 murine leukemia cells to antineoplastic agents following transfection with human DNA topoisomerase II alpha', 'volume': '17', 'author': 'McPherson', 'year': '1997', 'journal-title': 'Anticancer Res.'}
/ Anticancer Res. / Selective sensitization of adriamycin-resistant P388 murine leukemia cells to antineoplastic agents following transfection with human DNA topoisomerase II alpha by McPherson (1997)10.1016/S0005-2736(02)00507-2
/ Biochim. Biophys. Acta / Formation of transition metal-doxorubicin complexes inside liposomes by Abraham (2002)
Dates
Type | When |
---|---|
Created | 20 years, 3 months ago (May 6, 2005, 6:48 p.m.) |
Deposited | 5 years, 4 months ago (April 7, 2020, 3:39 a.m.) |
Indexed | 5 months, 1 week ago (March 19, 2025, 11:51 a.m.) |
Issued | 20 years, 2 months ago (June 1, 2005) |
Published | 20 years, 2 months ago (June 1, 2005) |
Published Print | 20 years, 2 months ago (June 1, 2005) |
@article{Dos_Santos_2005, title={Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity}, volume={105}, ISSN={0168-3659}, url={http://dx.doi.org/10.1016/j.jconrel.2005.03.007}, DOI={10.1016/j.jconrel.2005.03.007}, number={1–2}, journal={Journal of Controlled Release}, publisher={Elsevier BV}, author={Dos Santos, Nancy and Waterhouse, Dawn and Masin, Dana and Tardi, Paul G. and Karlsson, Göran and Edwards, Katarina and Bally, Marcel B.}, year={2005}, month=jun, pages={89–105} }